Comorbidities and Cardiovascular Disease Risk in Older Breast Cancer Survivors

被引:1
作者
Hague, Reina [1 ]
Prout, Marianne [3 ]
Geiger, Ann M. [4 ]
Kamineni, Aruna [5 ]
Thwin, Soe Soe [3 ,6 ]
Avila, Chantal [1 ]
Silliman, Rebecca A. [2 ]
Quinn, Virginia [1 ]
Yood, Marianne Ulcickas [7 ]
机构
[1] Kaiser Permanente, Pasadena, CA USA
[2] Boston Med Ctr, Boston, MA USA
[3] Boston Univ, Sch Publ Hlth, Boston, MA USA
[4] Wake Forest Sch Med, Winston Salem, NC USA
[5] Grp Hlth Res Inst, Seattle, WA USA
[6] VA Healthcare Syst, Boston, MA USA
[7] Henry Ford Hlth Syst, Detroit, MI USA
基金
美国国家卫生研究院;
关键词
RADIATION-THERAPY; HEART-DISEASE; ADJUVANT RADIOTHERAPY; AROMATASE INHIBITORS; WOMEN; MORTALITY; POPULATION; MORBIDITY; TOXICITY; STROKE;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To evaluate cardiovascular disease (CVD) risk factors in older breast cancer survivors compared with a group of women without breast cancer. Study Design: The retrospective study included (1) women aged 65 or more years who were initially diagnosed with stage I or II breast cancer from 1990 to 1994 in 6 US health plans and who survived at least 5 years postdiagnosis (cases) and (2) a matched comparison group. They were followed for a maximum of 15 years. Methods: Data sources included medical charts and electronic health records. Cases (n = 1361) were matched on age, health plan site, and enrollment year to women in the comparison group (n = 1361). Subjects were followed to the first CVD outcome, health plan disenrollment, death, or study end, We compared rates of CVD in these 2 groups and used Cox proportional hazard models to estimate the hazard ratio (HR), considering body mass index, smoking history, diabetes, and hypertension. Results: The strongest predictors of CVD were smoking history (HR = 1.29; 95% confidence interval [CI], 1.15-1.46), diabetes (HR = 1.72; 95% CI, 1.48-1.99), and hypertension (HR = 1.48; 95% CI, 1.31-1.67) rather than breast cancer case-comparison status (HR = 0.97; 95% CI, 0.87-1.09). Conclusion: Results suggest that long-term prognosis in breast cancer patients is affected by management of preexisting conditions. Assessment of comorbid conditions and effective management of diabetes and hypertension in older breast cancer survivors may lead to longer overall survival.
引用
收藏
页码:86 / 92
页数:7
相关论文
共 33 条
[1]   Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis [J].
Amir, Eitan ;
Seruga, Bostjan ;
Niraula, Saroj ;
Carlsson, Lindsay ;
Ocana, Alberto .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (17) :1299-1309
[2]   Webinar Training: An acceptable, feasible and effective approach for multi-site medical record abstraction: The BOWII experience [J].
Avila C.C. ;
Quinn V.P. ;
Geiger A.M. ;
Kerby T.J. ;
St Charles M. ;
Clough-Gorr K.M. .
BMC Research Notes, 4 (1)
[3]  
Breslow N E, 1987, IARC Sci Publ, P1
[4]   Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer [J].
Chlebowski, Rowan ;
Cuzick, Jack ;
Amakye, Dereck ;
Bauerfeind, Ingo ;
Buzdar, Aman ;
Chia, Stephen ;
Cutuli, Bruno ;
Linforth, Rick ;
Maass, Nicolai ;
Noguchi, Shinzaburo ;
Robidoux, Andre ;
Verma, Sunil ;
Hadji, Peyman .
BREAST, 2009, 18 :S1-S11
[5]   Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer [J].
Correa, Candace R. ;
Litt, Harold I. ;
Hwang, Wei-Ting ;
Ferrari, Victor A. ;
Solin, Lawrence J. ;
Harris, Eleanor E. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (21) :3031-3037
[6]  
Correa Candace R, 2009, Eur J Cancer, V45 Suppl 1, P420, DOI 10.1016/S0959-8049(09)70073-5
[7]   Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer? Meta-analysis of randomized trials [J].
Cuppone, Federica ;
Bria, Emilio ;
Verma, Sunil ;
Pritchard, Kathleen I. ;
Gandhi, Sonal ;
Carlini, Paolo ;
Milella, Michele ;
Nistic, Cecilia ;
Terzoli, Edmondo ;
Cognetti, Francesco ;
Giannarelli, Diana .
CANCER, 2008, 112 (02) :260-267
[8]   RADIATION-RELATED HEART DISEASE: CURRENT KNOWLEDGE AND FUTURE PROSPECTS [J].
Darby, Sarah C. ;
Cutter, David J. ;
Boerma, Marjan ;
Constine, Louis S. ;
Fajardo, Luis F. ;
Kodama, Kazunori ;
Mabuchi, Kiyohiko ;
Marks, Lawrence B. ;
Mettler, Fred A. ;
Pierce, Lori J. ;
Trott, Klaus R. ;
Yeh, Edward T. H. ;
Shore, Roy E. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03) :656-665
[9]   Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300 000 women in US SEER cancer registries [J].
Darby, SC ;
McGale, P ;
Taylor, CW ;
Peto, R .
LANCET ONCOLOGY, 2005, 6 (08) :557-565
[10]   Radiation therapy, cardiac risk factors, and cardiac toxicity in early-stage breast cancer patients [J].
Doyle, John J. ;
Neugut, Alfred I. ;
Jacobson, Judith S. ;
Wang, Jian ;
McBride, Russell ;
Grann, Alison ;
Grann, Victor R. ;
Hershman, Dawn .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (01) :82-93